Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Risk Factors That May Increase Injection Site Sensitivity Certain patient characteristics increase the likelihood of noticeable injection site reactions
No lethal dose was reached in preclinical toxicology studies, and no significant adverse effects have been reported in published research
FDA guidance has flagged AOD-9604 as a bulk substance that may not qualify for 503A compounding, meaning standard compounding pharmacy access is legally uncertain in the US
Follow safety protocols and handle the compound in a controlled lab environment with personal protective equipment
US$ 29.63
US$ 23.90
US$ 26.84
US$ 20.09
